UK markets closed

Tristel Plc (TSTL.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
445.00-20.00 (-4.30%)
At close: 04:43PM BST

Tristel Plc

Lynx Business Park
Unit 1B Fordham Road
Snailwell CB8 7NY
United Kingdom
44 16 3872 1500
https://tristel.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 208

Key executives

NameTitlePayExercisedYear born
Mr. Paul Christopher SwinneyCEO & Executive Director450kN/A1957
Ms. Elizabeth A. DixonCFO & Executive Director327kN/A1970
Mr. Bart Victor Margaretha LeemansExecutive Director305kN/A1962
Ms. Heidi A. AllardUK Finance Director, Global Financial Controller & Company SecretaryN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand. Tristel plc was founded in 1993 and is headquartered in Snailwell, the United Kingdom.

Corporate governance

Tristel Plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.